Diabetes, Vol 48, Issue 8 1562-1571, Copyright © 1999 by American Diabetes Association

ARTICLES

Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle

ME Patti, A Virkamaki, EJ Landaker, CR Kahn and H Yki-Jarvinen
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA. pattim@joslab.harvard.edu

To explore potential cellular mechanisms by which activation of the hexosamine pathway induces insulin resistance, we have evaluated insulin signaling in conscious fasted rats infused for 2-6 h with saline, insulin (18 mU x kg(-1) x min(-1)), or insulin and glucosamine (30 micromol x kg(-1) x min(-1)) under euglycemic conditions. Glucosamine infusion increased muscle UDP-N-acetylglucosamine concentrations 3.9- and 4.3-fold over saline- or insulin-infused animals, respectively (P < 0.001). Glucosamine induced significant insulin resistance to glucose uptake both at the level of the whole body and in rectus abdominis muscle, and it blunted the insulin-induced increase in muscle glycogen content. At a cellular level, these metabolic effects were paralleled by inhibition of postreceptor insulin signaling critical for glucose transport and glycogen storage, including a 45% reduction in insulin-stimulated insulin receptor substrate (IRS)-1 tyrosine phosphorylation (P = 0.02), a 44% decrease in IRS-1 association with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase (P = 0.03), a 34% reduction in IRS-1-associated PI 3-kinase activity (P = 0.03), and a 51% reduction in insulin-stimulated glycogen synthase activity (P = 0.03). These alterations in postreceptor insulin signaling were time-dependent and paralleled closely the progressive inhibition of systemic glucose disposal from 2 to 6 h of glucosamine infusion. We also demonstrated that glucosamine infusion results in O-linked N-acetylglucosamine modification of IRS-1 and IRS-2. These data indicate that activation of the hexosamine pathway may directly modulate early postreceptor insulin signal transduction, perhaps via posttranslation modification of IRS proteins, and thus contribute to the insulin resistance induced by chronic hyperglycemia.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B A Biggee, C M Blinn, M Nuite, J E Silbert, and T E McAlindon Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis Ann Rheum Dis, February 1, 2007; 66(2): 260 - 262. [Abstract] [Full Text] [PDF]

				R. Muniyappa, R. J. Karne, G. Hall, S. K. Crandon, J. A. Bronstein, M. R. Ver, G. L. Hortin, and M. J. Quon Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects Diabetes, November 1, 2006; 55(11): 3142 - 3150. [Abstract] [Full Text] [PDF]

				L. R. Tannock, E. A. Kirk, V. L. King, R. LeBoeuf, T. N. Wight, and A. Chait Glucosamine Supplementation Accelerates Early but Not Late Atherosclerosis in LDL Receptor-Deficient Mice J. Nutr., November 1, 2006; 136(11): 2856 - 2861. [Abstract] [Full Text] [PDF]

				L. E. Ball, M. N. Berkaw, and M. G. Buse Identification of the Major Site of O-Linked {beta}-N-Acetylglucosamine Modification in the C Terminus of Insulin Receptor Substrate-1 Mol. Cell. Proteomics, February 1, 2006; 5(2): 313 - 323. [Abstract] [Full Text] [PDF]

				M. G. Buse Hexosamines, insulin resistance, and the complications of diabetes: current status Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8. [Abstract] [Full Text] [PDF]

				C. Guinez, M.-E. Losfeld, R. Cacan, J.-C. Michalski, and T. Lefebvre Modulation of HSP70 GlcNAc-directed lectin activity by glucose availability and utilization Glycobiology, January 1, 2006; 16(1): 22 - 28. [Abstract] [Full Text] [PDF]

				D. M. Lehman, D.-J. Fu, A. B. Freeman, K. J. Hunt, R. J. Leach, T. Johnson-Pais, J. Hamlington, T. D. Dyer, R. Arya, H. Abboud, et al. A Single Nucleotide Polymorphism in MGEA5 Encoding O-GlcNAc-selective N-Acetyl-{beta}-D Glucosaminidase Is Associated With Type 2 Diabetes in Mexican Americans Diabetes, April 1, 2005; 54(4): 1214 - 1221. [Abstract] [Full Text] [PDF]

				J. C. Jimenez-Chillaron, M. Hernandez-Valencia, C. Reamer, S. Fisher, A. Joszi, M. Hirshman, A. Oge, S. Walrond, R. Przybyla, C. Boozer, et al. {beta}-Cell Secretory Dysfunction in the Pathogenesis of Low Birth Weight-Associated Diabetes: A Murine Model Diabetes, March 1, 2005; 54(3): 702 - 711. [Abstract] [Full Text] [PDF]

				C. Weigert, C. Thamer, K. Brodbeck, A. Guirguis, F. Machicao, J. Machann, F. Schick, M. Stumvoll, A. Fritsche, H. U. Haring, et al. The -913 G/A Glutamine:Fructose-6-Phosphate Aminotransferase Gene Polymorphism Is Associated with Measures of Obesity and Intramyocellular Lipid Content in Nondiabetic Subjects J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1639 - 1643. [Abstract] [Full Text] [PDF]

				A. R. Gosmanov, G. E. Umpierrez, A. H. Karabell, R. Cuervo, and D. B. Thomason Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E8 - E15. [Abstract] [Full Text] [PDF]

				C. Cieniewski-Bernard, B. Bastide, T. Lefebvre, J. Lemoine, Y. Mounier, and J.-C. Michalski Identification of O-linked N-Acetylglucosamine Proteins in Rat Skeletal Muscle Using Two-dimensional Gel Electrophoresis and Mass Spectrometry Mol. Cell. Proteomics, June 1, 2004; 3(6): 577 - 585. [Abstract] [Full Text] [PDF]

				F. Andreozzi, C. D'Alessandris, M. Federici, E. Laratta, S. Del Guerra, S. Del Prato, P. Marchetti, R. Lauro, F. Perticone, and G. Sesti Activation of the Hexosamine Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Insulin Biosynthetic Pathway in RIN Pancreatic {beta}-Cells Endocrinology, June 1, 2004; 145(6): 2845 - 2857. [Abstract] [Full Text] [PDF]

				G. Parker, R. Taylor, D. Jones, and D. McClain Hyperglycemia and Inhibition of Glycogen Synthase in Streptozotocin-treated Mice: ROLE OF O-LINKED N-ACETYLGLUCOSAMINE J. Biol. Chem., May 14, 2004; 279(20): 20636 - 20642. [Abstract] [Full Text] [PDF]

				B. Cheatham Enough Is Enough: Nutrient Sensors and Insulin Resistance Endocrinology, May 1, 2004; 145(5): 2115 - 2117. [Full Text] [PDF]

				E. B. Arias, J. Kim, and G. D. Cartee Prolonged Incubation in PUGNAc Results in Increased Protein O-Linked Glycosylation and Insulin Resistance in Rat Skeletal Muscle Diabetes, April 1, 2004; 53(4): 921 - 930. [Abstract] [Full Text] [PDF]

				T. L. Steiler, D. Galuska, Y. Leng, A. V. Chibalin, M. Gilbert, and J. R. Zierath Effect of Hyperglycemia on Signal Transduction in Skeletal Muscle from Diabetic Goto-Kakizaki Rats Endocrinology, December 1, 2003; 144(12): 5259 - 5267. [Abstract] [Full Text] [PDF]

				D.-H. Han, M. M. Chen, and J. O. Holloszy Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1267 - E1272. [Abstract] [Full Text] [PDF]

				S. A. Whelan and G. W. Hart Proteomic Approaches to Analyze the Dynamic Relationships Between Nucleocytoplasmic Protein Glycosylation and Phosphorylation Circ. Res., November 28, 2003; 93(11): 1047 - 1058. [Abstract] [Full Text] [PDF]

				C. A. Haber, T. K. T. Lam, Z. Yu, N. Gupta, T. Goh, E. Bogdanovic, A. Giacca, and I. G. Fantus N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E744 - E753. [Abstract] [Full Text] [PDF]

				A. Sasaki, K. Hata, S. Suzuki, M. Sawada, T. Wada, K. Yamaguchi, M. Obinata, H. Tateno, H. Suzuki, and T. Miyagi Overexpression of Plasma Membrane-associated Sialidase Attenuates Insulin Signaling in Transgenic Mice J. Biol. Chem., July 18, 2003; 278(30): 27896 - 27902. [Abstract] [Full Text] [PDF]

				K. Sakai and D. R. Clemmons Glucosamine Induces Resistance to Insulin-Like Growth Factor I (IGF-I) and Insulin in Hep G2 Cell Cultures: Biological Significance of IGF-I/Insulin Hybrid Receptors Endocrinology, June 1, 2003; 144(6): 2388 - 2395. [Abstract] [Full Text] [PDF]

				G. J. Parker, K. C. Lund, R. P. Taylor, and D. A. McClain Insulin Resistance of Glycogen Synthase Mediated by O-Linked N-Acetylglucosamine J. Biol. Chem., March 14, 2003; 278(12): 10022 - 10027. [Abstract] [Full Text] [PDF]

				C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, H. U. Haring, and E. D. Schleicher Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes: Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase Diabetes, March 1, 2003; 52(3): 650 - 656. [Abstract] [Full Text] [PDF]

				J. L. E. Walgren, T. S. Vincent, K. L. Schey, and M. G. Buse High glucose and insulin promote O-GlcNAc modification of proteins, including alpha -tubulin Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E424 - E434. [Abstract] [Full Text] [PDF]

				M.-J. J. Pouwels, P. N. Span, C. J. Tack, A. J. Olthaar, C. G. J. Sweep, B. G. van Engelen, J. G. de Jong, J. A. Lutterman, and A. R. Hermus Muscle Uridine Diphosphate-Hexosamines Do Not Decrease Despite Correction of Hyperglycemia-Induced Insulin Resistance in Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5179 - 5184. [Abstract] [Full Text] [PDF]

				L. Ma, W. A. Rudert, J. Harnaha, M. Wright, J. Machen, R. Lakomy, S. Qian, L. Lu, P. D. Robbins, M. Trucco, et al. Immunosuppressive Effects of Glucosamine J. Biol. Chem., October 11, 2002; 277(42): 39343 - 39349. [Abstract] [Full Text] [PDF]

				M. G. Buse, K. A. Robinson, B. A. Marshall, R. C. Hresko, and M. M. Mueckler Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E241 - E250. [Abstract] [Full Text] [PDF]

				M. Federici, R. Menghini, A. Mauriello, M. L. Hribal, F. Ferrelli, D. Lauro, P. Sbraccia, L. G. Spagnoli, G. Sesti, and R. Lauro Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells Circulation, July 23, 2002; 106(4): 466 - 472. [Abstract] [Full Text] [PDF]

				K. Vosseller, L. Wells, M. D. Lane, and G. W. Hart Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes PNAS, April 16, 2002; 99(8): 5313 - 5318. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				R. Zhande, J. J. Mitchell, J. Wu, and X. J. Sun Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1 Mol. Cell. Biol., February 15, 2002; 22(4): 1016 - 1026. [Abstract] [Full Text] [PDF]

				S. T. Nadler, J. P. Stoehr, M. E. Rabaglia, K. L. Schueler, M. J. Birnbaum, and A. D. Attie Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1249 - E1254. [Abstract] [Full Text] [PDF]

				A. Virkamaki, E. Korsheninnikova, A. Seppala-Lindroos, S. Vehkavaara, T. Goto, J. Halavaara, A.-M. Hakkinen, and H. Yki-Jarvinen Intramyocellular Lipid Is Associated With Resistance to In Vivo Insulin Actions on Glucose Uptake, Antilipolysis, and Early Insulin Signaling Pathways in Human Skeletal Muscle Diabetes, October 1, 2001; 50(10): 2337 - 2343. [Abstract] [Full Text]

				P. Peltoniemi, H. Yki-Järvinen, V. Oikonen, A. Oksanen, T. O. Takala, T. Rönnemaa, M. Erkinjuntti, M. J. Knuuti, and P. Nuutila Resistance to Exercise-Induced Increase in Glucose Uptake During Hyperinsulinemia in Insulin-Resistant Skeletal Muscle of Patients With Type 1 Diabetes Diabetes, June 1, 2001; 50(6): 1371 - 1377. [Abstract] [Full Text]

				M.-J. J. Pouwels, J. R. Jacobs, P. N. Span, J. A. Lutterman, P. Smits, and C. J. Tack Short-Term Glucosamine Infusion Does Not Affect Insulin Sensitivity in Humans J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2099 - 2103. [Abstract] [Full Text]

				L. Wells, K. Vosseller, and G. W. Hart Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc Science, March 23, 2001; 291(5512): 2376 - 2378. [Abstract] [Full Text]

				K. Liu, A. J. Paterson, E. Chin, and J. E. Kudlow Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: Linkage of O-linked GlcNAc to beta cell death PNAS, March 14, 2000; 97(6): 2820 - 2825. [Abstract] [Full Text] [PDF]

				A. C. Gazdag, T. J. Wetter, R. T. Davidson, K. A. Robinson, M. G. Buse, A. J. Yee, L. P. Turcotte, and G. D. Cartee Lower calorie intake enhances muscle insulin action and reduces hexosamine levels Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R504 - R512. [Abstract] [Full Text] [PDF]

				M. Hawkins, M. Hu, J. Yu, H. Eder, P. Vuguin, L. She, N. Barzilai, M. Leiser, J. M. Backer, and L. Rossetti Discordant Effects of Glucosamine on Insulin-stimulated Glucose Metabolism and Phosphatidylinositol 3-Kinase Activity J. Biol. Chem., October 29, 1999; 274(44): 31312 - 31319. [Abstract] [Full Text] [PDF]

				H. Kaneto, G. Xu, K.-H. Song, K. Suzuma, S. Bonner-Weir, A. Sharma, and G. C. Weir Activation of the Hexosamine Pathway Leads to Deterioration of Pancreatic beta -Cell Function through the Induction of Oxidative Stress J. Biol. Chem., August 10, 2001; 276(33): 31099 - 31104. [Abstract] [Full Text] [PDF]

				M. Ristow, M. F. Pfister, A. J. Yee, M. Schubert, L. Michael, C.-Y. Zhang, K. Ueki, M. D. Michael II, B. B. Lowell, and C. R. Kahn Frataxin activates mitochondrial energy conversion and oxidative phosphorylation PNAS, October 24, 2000; 97(22): 12239 - 12243. [Abstract] [Full Text] [PDF]

				B. A. Nelson, K. A. Robinson, and M. G. Buse Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E497 - E506. [Abstract] [Full Text] [PDF]